Perspectives on the translation of in-vitro studies to precision medicine in Cystic Fibrosis
Recent strides towards precision medicine in Cystic Fibrosis (CF) have been made possible by patient-derived in-vitro assays with the potential to predict clinical response to small molecule-based therapies. Here, we discuss the status of primary and stem-cell derived tissues used to evaluate the pr...
Main Authors: | Marie-Pier Dumas, Sunny Xia, Christine E. Bear, Felix Ratjen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396421004540 |
Similar Items
-
Gene therapy for cystic fibrosis: new tools for precision medicine
by: Jin-A Lee, et al.
Published: (2021-10-01) -
Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
by: Iwona Pranke, et al.
Published: (2019-02-01) -
New Therapies to Correct the Cystic Fibrosis Basic Defect
by: Christelle Bergeron, et al.
Published: (2021-06-01) -
Pregnancy in Cystic Fibrosis—Past, Present, and Future
by: Michal Gur, et al.
Published: (2023-02-01) -
Activity of lumacaftor is not conserved in zebrafish Cftr bearing the major cystic fibrosis‐causing mutation
by: Onofrio Laselva, et al.
Published: (2019-10-01)